KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 107 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,616,305 | -29.8% | 243,151 | -2.3% | 0.00% | 0.0% |
| Q4 2022 | $3,729,465 | +8.4% | 248,963 | -7.0% | 0.00% | 0.0% |
| Q3 2022 | $3,439,000 | +27.9% | 267,766 | -3.5% | 0.00% | 0.0% |
| Q2 2022 | $2,688,000 | -2.5% | 277,384 | 0.0% | 0.00% | – |
| Q1 2022 | $2,757,000 | -22.1% | 277,384 | -7.7% | 0.00% | -100.0% |
| Q4 2021 | $3,538,000 | -23.0% | 300,641 | -25.4% | 0.00% | 0.0% |
| Q3 2021 | $4,592,000 | -18.2% | 403,200 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $5,617,000 | +203.1% | 403,200 | +302.8% | 0.00% | – |
| Q1 2021 | $1,853,000 | +4.7% | 100,100 | 0.0% | 0.00% | – |
| Q4 2020 | $1,769,000 | +44.2% | 100,100 | +25.0% | 0.00% | – |
| Q3 2020 | $1,227,000 | +109.7% | 80,100 | +137.6% | 0.00% | – |
| Q2 2018 | $585,000 | – | 33,719 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $8,988,000 | 1.31% |
| Rubric Capital Management LP | 1,569,503 | $23,511,155 | 1.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 307,283 | $4,603,099 | 0.99% |
| HHLR ADVISORS, LTD. | 2,623,924 | $39,306,382 | 0.83% |
| Parkman Healthcare Partners LLC | 191,307 | $2,865,779 | 0.76% |
| AlphaCentric Advisors LLC | 45,000 | $674,100 | 0.67% |
| RICE HALL JAMES & ASSOCIATES, LLC | 697,162 | $10,443,487 | 0.60% |
| Lion Point Capital, LP | 346,500 | $3,689,000 | 0.52% |
| EAM Global Investors LLC | 116,864 | $1,750,623 | 0.45% |
| Jackson Creek Investment Advisors LLC | 61,609 | $923 | 0.41% |